Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
3,138.2
-0.6 (-0.02%)

 

  • STI Straits Times Index
    3,138.2
    -0.6 (-0.02%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,513.6
    -1.0 (-0.07%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    25,249.3
    162.9 (0.65%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,317.6
    -63.6 (-1.88%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    27,749.6
    -220.6 (-0.79%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,097.0
    -
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 239.3M
  • Value: 267.6M
  • Rise: 138
  • Fall: 76
  • Unch: 547

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
MM2 Asia0.071+0.004
Sembcorp Marine0.110+0.001
Metal Component0.059+0.002
Olam Intl1.280-0.060
Leader Env0.082+0.004
Golden Agri-Res0.210-
KTL Global^0.117-0.005
GSS Energy0.068+0.001
Singtel2.240+0.010
Mercurius0.064+0.002

World Indices

World Indices
Name Last Change
Nasdaq 14,660.6 -180.1
HSI 25,242.5 +156.1
HSCEI 8,990.6 +111.0
Jakarta 6,094.5 -2.5
Nikkei 225 27,697.3 -272.9
SSE Comp 3,333.7 -47.5
Shanghai A 3,493.9 -49.8
Shanghai B 253.5 -3.4
KOSPI 3,230.6 -2.0

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

OYSTER POINT PHARMA INC OYSTER POINT PHARMA INC
Updated on 27 Jul 2021 (End of trading day)
Last (USD): 15.410 Change: -0.890 High: 16.360 Remarks: -
Change (%): -5.46 Low: 15.300
Open 16.250 Yesterday's Close 16.3
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 47,270 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -2.71463 Trailing EPS (USD) e -2.80663 NAV (USD) b 6.5690
PE a - Trailing PE f - Price / NAV b 2.3459
Dividend (USD) d - Cash In Hand (USD) g 6.7716 Issued & Paid-up Shares c 25,977,800
Dividend Yield (%) d - Price / Cash In Hand g 2.276 Treasury Shares h -
Market Cap (M) 400.318 Enterprise Value (M) 225.329
Piotroski F Score 1 Exchange Code OYST Par Value ( $ ) n.a.
52 Weeks Volatility (%) 60.33 Free Float (%) 39.2
Sector & Industry Health Technology - Pharmaceuticals: Major
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 07 May 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 30 Oct 2019.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference OYSTER POINT PHARMA INC NASDAQ 400.318 - - 2.3459 -
Industry Pharmaceuticals: Major NASDAQ 2,394.326 85.972 90.486 3.3660 1.409
Local Peer ROYALTY PHARMA PLC NASDAQ 23,798.790 24.408 24.464 4.8746 0.489
Local Peer VIATRIS INC NASDAQ 16,812.461 - - 0.7851 -
Local Peer CUREVAC NV NASDAQ 9,752.341 - - - -
Local Peer HUTCHMED (CHINA) LIMITED SPON ADS EACH REPR 5 ORD SHS NASDAQ 6,299.398 - - 14.7083 -
Local Peer LEGEND BIOTECH CORP SPON ADS EACH REP 2 ORD SHS NASDAQ 6,023.923 - - 29.1769 -
Local Peer ASCENDIS PHARMA A/S SPON ADR EACH REP 1 ORD SHS NASDAQ 6,068.958 - - 6.4320 -
Local Peer APELLIS PHARMACEUTICALS INC NASDAQ 5,279.785 - - 102.2129 -
Local Peer I MAB SPON ADS EACH REP 2.3 ORD SHS NASDAQ 4,671.630 68.472 68.472 5.4293 -
Local Peer REATA PHARMACEUTICALS INC NASDAQ 4,506.435 - - 12.2015 -
Local Peer ALLAKOS INC NASDAQ 4,323.075 - - 7.0174 -
Local Peer IMMUNITYBIO INC NASDAQ 4,134.668 - - -22.2567 -
Local Peer SPRINGWORKS THERAPEUTICS INC NASDAQ 4,148.116 - - 7.7579 -
Other Local Peers GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 (NASDAQ), CEREVEL THERAPEUTICS HLDGS INC (NASDAQ), KARUNA THERAPEUTICS INC (NASDAQ), TURNING POINT THERAPEUTICS INC (NASDAQ), NEKTAR THERAPEUTICS (NASDAQ), DICERNA PHARMACEUTICALS INC. (NASDAQ), IGM BIOSCIENCES INC (NASDAQ), ATAI LIFE SCIENCES NV (NASDAQ), OPKO HEALTH INC (NASDAQ), ERASCA INC (NASDAQ), ATEA PHARMACEUTICALS INC (NASDAQ), QUANTERIX CORPORATION (NASDAQ), CENTESSA PHARMACEUTICALS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), HARMONY BIOSCIENCES HLDGS INC (NASDAQ), Y-MABS THERAPEUTICS INC (NASDAQ), CONNECT BIOPHARMA HLDGS LTD ADS EACH REP ONE ORD SHARE (NASDAQ), DAY ONE BIOPHARMACEUTICALS INC (NASDAQ), NURIX THERAPEUTICS INC (NASDAQ), KRYSTAL BIOTECH INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), REPARE THERAPEUTICS INC (NASDAQ), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), KRONOS BIO INC (NASDAQ), GENERATION BIO CO (NASDAQ), FORMA THERAPEUTICS HLDGS INC (NASDAQ), SILVERBACK THERAPEUTICS INC (NASDAQ), CULLINAN ONCOLOGY INC (NASDAQ), PETIQ INC (NASDAQ), MIND MEDICINE (MINDMED) INC (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), PHATHOM PHARMACEUTICALS INC (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), NRX PHARMACEUTICALS INC (NASDAQ), ESSA PHARMA INC (NASDAQ), KINNATE BIOPHARMA INC (NASDAQ), OLEMA PHARMACEUTICALS INC (NASDAQ), KEROS THERAPEUTICS INC (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), GH RESEARCH PLC (NASDAQ), POINT BIOPHARMA GLOBAL INC (NASDAQ), SUTRO BIOPHARMA INC (NASDAQ), ANNEXON INC (NASDAQ), AKERO THERAPEUTICS INC (NASDAQ), CALLIDITAS THERAPEUTICS AB SPON ADS EACH REP 2 ORD SHS (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), ADAGENE INC SPON ADS EACH REP 1.25 ORD SHS (NASDAQ), PRAXIS PRECISION MEDICINES INC (NASDAQ), CRINETICS PHARMACEUTICALS INC (NASDAQ), ALIGOS THERAPEUTICS INC (NASDAQ), ACUMEN PHARMACEUTICALS INC (NASDAQ), ORIC PHARMACEUTICALS INC (NASDAQ), EVOLUS INC (NASDAQ), GOSSAMER BIO INC (NASDAQ), TALARIS THERAPEUTICS INC (NASDAQ), CHINOOK THERAPEUTICS INC (NASDAQ), VERU INC (NASDAQ), WEREWOLF THERAPEUTICS INC (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), AC IMMUNE SA (NASDAQ), VACCITECH PLC ADR EACH REPR 1 ORD SH SPON (NASDAQ), TARSUS PHARMACEUTICALS INC (NASDAQ), ALPHA TEKNOVA INC (NASDAQ), NANOBIOTIX S A SPON ADS EACH REP 1 ORD SHS (NASDAQ), EVELO BIOSCIENCES INC (NASDAQ), TCR2 THERAPEUTICS INC (NASDAQ), CLENE INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), SIGA TECHNOLOGIES INC (NASDAQ), PHARVARIS NV (NASDAQ), INOZYME PHARMA INC (NASDAQ), BOLT BIOTHERAPEUTICS INC (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), ALZAMEND NEURO INC (NASDAQ), AMRYT PHARMA PLC (NEW) SPON ADS EACH REP 5 ORD SHS (NASDAQ), PROVENTION BIO INC (NASDAQ), BEYONDSPRING INC (NASDAQ), GRITSTONE BIO INC (NASDAQ), XOMA CORP (NASDAQ), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), BIOMEA FUSION INC (NASDAQ), CODIAK BIOSCIENCES INC (NASDAQ), ATHENEX INC (NASDAQ), 89BIO INC (NASDAQ), FUSION PHARMACEUTICALS INC (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), ANGION BIOMEDICA CORP (NASDAQ), VECTIVBIO HLDG AG (NASDAQ), DURECT CORP (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), GAMIDA CELL LTD (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), CLEARSIDE BIOMEDICAL INC (NASDAQ), IMPEL NEUROPHARMA INC (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), VINCERX PHARMA INC (NASDAQ), 180 LIFE SCIENCES CORP (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), NEXIMMUNE INC (NASDAQ), ACHILLES THERAPEUTICS PLC ADS EACH REPR 1 SHARE SPON (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), FULCRUM THERAPEUTICS INC (NASDAQ), IMMUNIC INC (NASDAQ), MUSTANG BIO INC (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), KALA PHARMACEUTICALS INC (NASDAQ), EYEPOINT PHARMACEUTICALS INC (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), HOOKIPA PHARMA INC (NASDAQ), HARROW HEALTH INC (NASDAQ), TFF PHARMACEUTICALS INC (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), XERIS PHARMACEUTICALS INC (NASDAQ), RENEO PHARMACEUTICALS INC (NASDAQ), OBSEVA SA (NASDAQ), CHECKPOINT THERAPEUTICS INC (NASDAQ), TRICIDA INC (NASDAQ), 4D PHARMA PLC SPONS ADR EACH REP 8 ORD SHS (NASDAQ), ONCTERNAL THERAPEUTICS INC (NASDAQ), ORPHAZYME A/S SPON ADS REP 1 ORD SHS (NASDAQ), PHASEBIO PHARMACEUTICALS INC (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), ANEBULO PHARMACEUTICALS INC (NASDAQ), VTV THERAPEUTICS INC (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), AYALA PHARMACEUTICALS INC (NASDAQ), QILIAN INTERNATIONAL HLDG GROUP LTD (NASDAQ), LANTERN PHARMA INC (NASDAQ), IMARA INC (NASDAQ), CYCLERION THERAPEUTICS INC (NASDAQ), GENPREX INC (NASDAQ), POLYPID LTD (NASDAQ), VYNE THERAPEUTICS INC (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), LOGICBIO THERAPEUTICS INC (NASDAQ), ODONATE THERAPEUTICS INC (NASDAQ), AQUESTIVE THERAPEUTICS INC (NASDAQ), LIQUIDIA CORPORATION (NASDAQ), NOVAN INC (NASDAQ), ENTERA BIO LTD (NASDAQ), NEUBASE THERAPEUTICS INC (NASDAQ), EYENOVIA INC (NASDAQ), F-STAR THERAPEUTICS INC (NASDAQ), REGENCELL BIOSCIENCE HLDGS LTD (NASDAQ), GALECTO INC (NASDAQ), PROPHASE LABS INC (NASDAQ), MEDIWOUND LTD (NASDAQ), TEMPEST THERAPEUTICS INC (NASDAQ), AYTU BIOPHARMA INC (NASDAQ), AERPIO PHARMACEUTICALS INC (NASDAQ), AILERON THERAPEUTICS INC (NASDAQ), APTORUM GROUP LIMITED (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), GRAYBUG VISION INC (NASDAQ), APREA THERAPEUTICS INC (NASDAQ), ELEDON PHARMACEUTICALS INC (NASDAQ), PROTARA THERAPEUTICS INC (NASDAQ), YUMANITY THERAPEUTICS INC (NASDAQ), PURPLE BIOTECH LTD SPON ADS EACH REP 10 ORD SHS (NASDAQ), LYRA THERAPEUTICS INC (NASDAQ), CORVUS PHARMACEUTICALS INC (NASDAQ), ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), EDESA BIOTECH INC (NASDAQ), OCUPHIRE PHARMA INC (NASDAQ), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), UNIVERSE PHARMACEUTICALS INC (NASDAQ), INHIBIKASE THERAPEUTICS INC (NASDAQ), SYNAPTOGENIX INC (NASDAQ), MANNATECH INC (NASDAQ), ALLENA PHARMACEUTICALS INC (NASDAQ), ARIDIS PHARMACEUTICAL INC (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), ASSERTIO HOLDINGS INC (NASDAQ), BAUDAX BIO INC (NASDAQ), ACURX PHARMACEUTICALS INC (NASDAQ), VIRIOS THERAPEUTICS INC (NASDAQ), ADIAL PHARMACEUTICALS INC (NASDAQ), CNS PHARMACEUTICALS INC (NASDAQ), TELIGENT INC NEW (NASDAQ), TREVI THERAPEUTICS INC (NASDAQ), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), REVIVA PHARMACEUTICALS HOLDINGS INC (NASDAQ), PANBELA THERAPEUTICS INC (NASDAQ), PAINREFORM LTD (NASDAQ), NLS PHARMACEUTICS LTD (NASDAQ), ACER THERAPEUTICS INC (NASDAQ), HOTH THERAPEUTICS INC (NASDAQ), VALLON PHARMACEUTICALS INC (NASDAQ), AVENUE THERAPEUTICS INC (NASDAQ), PETROS PHARMACEUTICALS INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ), TITAN PHARMACEUTICAL INC (NASDAQ), VIRPAX PHARMA INC (NASDAQ), CHINA SXT PHARMACEUTICALS INC (NASDAQ)
Global Peer JOHNSON & JOHNSON NYSE 454,682.844 30.901 25.591 - 2.304
Global Peer PFIZER INC NYSE 235,662.749 24.507 21.248 3.4343 3.614
Global Peer ELI LILLY AND COMPANY NYSE 233,599.553 37.716 38.342 33.8616 1.212
Global Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 222,311.234 27.378 24.717 4.1137 2.111
Global Peer ABBVIE INC NYSE 208,343.311 45.729 40.980 15.1965 4.101
Global Peer MERCK & CO INC NYSE 197,120.871 27.893 28.048 7.3157 3.183
Global Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 158,910.004 24.661 23.638 17.1905 1.501
Global Peer BRISTOL-MYERS SQUIBB CO NYSE 150,767.936 - - 4.0092 2.739
Global Peer GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 NYSE 99,425.997 13.486 14.644 4.8479 5.236
Global Peer WUXI APPTEC HKEx 461,877.746 139.164 96.954 11.0338 0.225
Other Global Peers TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS (NYSE), HANSOH PHARMA (HKEx), INNOVENT BIO (HKEx), CANSINOBIO-B (HKEx), SINOPHARM (HKEx), BIOHAVEN PHARMACEUTICAL HLDG CO LTD (NYSE), ORGANON & CO (NYSE), HUTCHMED (HKEx), SH PHARMA (HKEx), JUNSHI BIO (HKEx), HYGEIA HEALTH (HKEx), REMEGEN-B (HKEx), CMS (HKEx), AKESO-B (HKEx), INNOCARE-B (HKEx), BAIYUNSHAN PH (HKEx), CHINARES PHARMA (HKEx), EMERGENT BIOSOLUTIONS INC (NYSE), SIMCERE PHARMA (HKEx), TRAD CHI MED (HKEx), CHINAGRANDPHARM (HKEx), CSTONE PHARMA-B (HKEx), EVEREST MED-B (HKEx), HENLIUS (HKEx), CARSGEN-B (HKEx), SSY GROUP (HKEx), HEPALINK (HKEx), OCUMENSION-B (HKEx), ADC THERAPEUTICS SA (NYSE), ZYMEWORKS INC (NYSE), AMNEAL PHARMACEUTICALS INC (NYSE), UNITED LAB (HKEx), ANTENGENE-B (HKEx), BROOKLYN IMMUNO THERAPEUTICS INC (NYSE American), Kimia Farma Tbk. (IDX), TONGRENTANGCM (HKEx), IMMUNOTECH-B (HKEx), SCICLONE PHARMA (HKEx), CKLIFE SCIENCES (HKEx), ANNOVIS BIO INC (NYSE American), SHINEWAY PHARM (HKEx), ZHAOKE OPHTH-B (HKEx), HUA MEDICINE-B (HKEx), Soho Global Health Tbk. (IDX), IGBB (Bursa), RACE ONCOLOGY LTD (ASX), STARPHARMA HOLDINGS LIMITED (ASX), PYC THERAPEUTICS LIMITED (ASX), AFT PHARMACEUTICALS LTD (ASX), DAWNRAYS PHARMA (HKEx), BSTEAD (Bursa), TOT BIOPHARM-B (HKEx), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), PHARMA (Bursa), FUSEN PHARM (HKEx), IP (SET), LANNETT CO INC (NYSE), CH BIOTECH SER (HKEx), NOXOPHARM LTD (ASX), ZHONGZHIPHARM (HKEx), RECCE PHARMACEUTICALS LTD (ASX), IX Biopharma (SGX), Merck Tbk. (IDX), CRESO PHARMA LTD (ASX), NEW RAY MEDIC (HKEx), CHARMACY PHAR (HKEx), KOTRA (Bursa), Phapros Tbk. (IDX), PAK FAH YEOW (HKEx), NC HEALTHCARE (HKEx), Hyphens Pharma (SGX), BIOHLDG (Bursa), NOVA (Bursa), MODERN CHI MED (HKEx), EXOPHARM LTD (ASX), INVION LTD (ASX), NEP INTERLONG (HKEx), AGEX THERAPEUTICS INC (NYSE American), WAI YUEN TONG (HKEx), MEDLAB CLINICAL LIMITED (ASX), PALLA PHARMA LTD (ASX), TBG DIAGNOSTICS LTD (ASX), PURAPHARM (HKEx), TIMBER PHARMACEUTICALS INC (NYSE American), SANAI HEALTH GP (HKEx), JCT (SET), SUNZEN (Bursa), PHARMAXIS (ASX), EXTRAWELL PHAR (HKEx), ONCOSIL MEDICAL LIMITED (ASX), TALI DIGITAL LIMITED (ASX), IMMURON LIMITED (ASX), ACRUX (ASX), ISLAND PHARMACEUTICALS LTD (ASX), SINOLIFE UTD (HKEx), SUDA PHARMACEUTICALS LTD (ASX), PASHUN INT'L (HKEx), FIJI KAVA LTD (ASX), CELLMID LIMITED (ASX), FARMAFORCE LTD (ASX), Pharmesis Intl (SGX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --2.660
-14.72 %
10 Days --2.210
-12.54 %
20 Days --1.900
-10.98 %
Medium Term Return 3 Months --5.700
-27.00 %
6 Months --5.430
-26.06 %
1 Year --8.150
-34.59 %
Annualised Return Annualised --
-34.59 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 15.750 - 28.000 Change From 1 Year Low -0.340 % Change From 1 Year Low (%) -2.16
Change From 1 Year High -12.590 % Change From 1 Year High (%) -44.96
2 Years Range 13.260 - 41.370 Change From 2 Years Low +2.150 % Change From 2 Years Low (%) +16.21
Change From 2 Years High -25.960 % Change From 2 Years High (%) -62.75
5 Years Range 13.260 - 41.370 Change From 5 Years Low +2.150 % Change From 5 Years Low (%) +16.21
Change From 5 Years High -25.960 % Change From 5 Years High (%) -62.75
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Oyster Point Pharma, Inc. engages in the development and commercialization of pharmaceutical therapies to treat ocular surface diseases. Its product candidate, OC-01, is a nicotinic acetylcholine receptor agonist, which is being developed as a nasal spray to treat the signs and symptoms of dry eye disease. The company was founded by Michael and is Ackermann in June 30, 2015 headquartered in Princeton, NJ.

Historical Price Data

Date Open High Low Close Volume VWAP
26 Jul 2021 16.280 16.560 15.280 16.300 40,338 -
23 Jul 2021 16.920 16.970 16.030 16.310 38,352 -
22 Jul 2021 17.850 18.260 16.660 16.740 37,930 -
21 Jul 2021 17.672 18.250 17.360 17.700 37,264 -
20 Jul 2021 17.460 18.170 17.270 18.070 52,001 -
19 Jul 2021 16.510 17.385 16.510 17.260 26,616 -
16 Jul 2021 16.540 17.090 16.540 16.630 25,162 -
15 Jul 2021 16.436 16.690 16.160 16.620 23,404 -
14 Jul 2021 17.610 17.660 16.410 16.470 32,295 -
13 Jul 2021 17.570 17.665 16.950 17.620 29,970 -
12 Jul 2021 17.530 17.715 16.650 17.550 27,025 -
09 Jul 2021 17.480 17.800 17.030 17.370 43,303 -
08 Jul 2021 16.170 18.390 16.160 17.350 70,463 -
07 Jul 2021 17.040 17.645 15.750 16.410 173,898 -
06 Jul 2021 16.800 17.170 16.253 17.110 53,696 -
02 Jul 2021 16.930 17.100 16.050 16.850 86,966 -
01 Jul 2021 17.490 18.850 16.830 17.070 82,749 -
30 Jun 2021 17.110 17.770 16.950 17.190 29,110 -
29 Jun 2021 17.950 17.950 16.990 17.310 64,585 -
28 Jun 2021 19.490 19.610 17.550 17.890 74,441 -
25 Jun 2021 20.630 20.700 19.340 19.400 896,605 -
24 Jun 2021 19.010 20.650 19.010 20.430 65,719 -
Summary
Current 2 Weeks
(13 Jul 2021 to 26 Jul 2021)
17.570 18.260 15.280 16.300 343,332 -
Previous 2 Weeks
(28 Jun 2021 to 12 Jul 2021)
19.490 19.610 15.280 17.550 706,236 -
4 Weeks from
(28 May 2021 to 25 Jun 2021)
18.030 18.260 15.280 19.400 1,910,393 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.